Compugen (CGEN) Reports In-Line Q3 EPS

Compugen (NASDAQ: CGEN) reported Q3 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $1.89 million versus the consensus estimate of $3.13 million.

For earnings history and earnings-related data on Compugen (CGEN) click here.

You May Also Be Interested In

• Kroger (KR) Tops Q2 EPS by 3c, Misses on Revenue; Offers FY27 EPS Guidance
• MannKind (MNKD) Reiterated at Overweight by Cantor Fitzgerald on Positive MNKD-201 Ph1 Data
• Lazard AUM rises to $290.3 billion at end of August 2026